Based on the Wall Street analyst consensus for 52 of IHE’s holdings.
IHE 12 Month Forecast
Average Price Target
$129.99â–²(17.08% Upside)
Based on Wall Street analyst 12-month price targets for 52 of iShares U.S. Pharmaceuticals ETF’s holdings in the last 3 months. The average price target is $129.99 with a high forecast of $152.61 and a low forecast of $97.27. The average price target represents a 17.08% change from the last price of $111.03.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$152.61
Average$129.99
Low$97.27
Past 12 Months12 Month Forecast$75$94.5$114$133.5$153Feb2026May2026Aug2026Nov2026Nov2027
What is IHE’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 52 of IHE’s holdings, iShares U.S. Pharmaceuticals ETF’s 12-month average price target is $129.99.
What is IHE’s upside potential, based on the analysts’ average price target?
IHE’s average price target of $129.99 represents a 17.08% upside from its last price of $111.03.
Is IHE a Buy, Sell or Hold?
iShares U.S. Pharmaceuticals ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 52 of IHE’s holdings: 46 rated Buy, 6 rated Hold and 0 rated Sell.
What is iShares U.S. Pharmaceuticals ETF’s price target?
The average price target for iShares U.S. Pharmaceuticals ETF is $129.99, based on Wall Street analyst 12-month price targets for 52 of IHE’s holdings, issued in the past 3 months. The highest price target is $152.61 and the lowest is $97.27. The average price target represents a 17.08% increase from the last price of $111.03.
What is IHE’s expense ratio?
IHE’s expense ratio is 0.37%.
How many holdings does IHE have?
IHE holds 54 assets.
How can I buy shares of IHE?
You can buy shares of IHE through a brokerage account. Compare brokers on our Best Online Brokers page.